Cargando…
Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis
BACKGROUND: The secretory leukocyte protease inhibitor (SLPI) exerts wide ranging effects on inflammatory pathways and is upregulated in EAE but the biological role of SLPI in EAE, an animal model of multiple sclerosis is unknown METHODS: To investigate the pathophysiological effects of SLPI within...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352067/ https://www.ncbi.nlm.nih.gov/pubmed/22436018 http://dx.doi.org/10.1186/1471-2202-13-30 |